Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized DNase for Severe COVID-19
NCT04541979Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Jun 2020
- Primary completion
- Jan 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in coronavirus disease 2019 (COVID-19), sponsored by Region Skåne. Started Jun 2020; status: completed.
02
Drugs
dornase alfa
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04541979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04541979.